nodes	percent_of_prediction	percent_of_DWPC	metapath
Nilutamide—CYP2C8—Mometasone—systemic scleroderma	0.275	0.473	CbGbCtD
Nilutamide—CYP2C9—Leflunomide—systemic scleroderma	0.124	0.213	CbGbCtD
Nilutamide—CYP2C8—Mycophenolate mofetil—systemic scleroderma	0.109	0.188	CbGbCtD
Nilutamide—CYP2C19—Prednisone—systemic scleroderma	0.0734	0.126	CbGbCtD
Nilutamide—CYP2C9—cardial valve—systemic scleroderma	0.0198	0.594	CbGeAlD
Nilutamide—POR—tendon—systemic scleroderma	0.00192	0.0576	CbGeAlD
Nilutamide—POR—lung—systemic scleroderma	0.00168	0.0506	CbGeAlD
Nilutamide—AR—connective tissue—systemic scleroderma	0.00165	0.0495	CbGeAlD
Nilutamide—AR—smooth muscle tissue—systemic scleroderma	0.00151	0.0453	CbGeAlD
Nilutamide—AR—skin of body—systemic scleroderma	0.00149	0.0447	CbGeAlD
Nilutamide—AR—digestive system—systemic scleroderma	0.00119	0.0358	CbGeAlD
Nilutamide—AR—tendon—systemic scleroderma	0.00113	0.034	CbGeAlD
Nilutamide—CYP2C19—digestive system—systemic scleroderma	0.0011	0.0331	CbGeAlD
Nilutamide—AR—lung—systemic scleroderma	0.000995	0.0299	CbGeAlD
Nilutamide—CYP2C9—digestive system—systemic scleroderma	0.000856	0.0257	CbGeAlD
Nilutamide—Tension—Lisinopril—systemic scleroderma	0.000736	0.00191	CcSEcCtD
Nilutamide—Discomfort—Leflunomide—systemic scleroderma	0.000734	0.0019	CcSEcCtD
Nilutamide—Loss of consciousness—Mycophenolic acid—systemic scleroderma	0.000732	0.0019	CcSEcCtD
Nilutamide—Nervousness—Lisinopril—systemic scleroderma	0.000729	0.00189	CcSEcCtD
Nilutamide—Visual impairment—Mycophenolate mofetil—systemic scleroderma	0.000728	0.00189	CcSEcCtD
Nilutamide—Dry mouth—Leflunomide—systemic scleroderma	0.000727	0.00189	CcSEcCtD
Nilutamide—Cough—Mycophenolic acid—systemic scleroderma	0.000727	0.00189	CcSEcCtD
Nilutamide—Back pain—Lisinopril—systemic scleroderma	0.000726	0.00188	CcSEcCtD
Nilutamide—Vomiting—Pentoxifylline—systemic scleroderma	0.000725	0.00188	CcSEcCtD
Nilutamide—Rash—Pentoxifylline—systemic scleroderma	0.000719	0.00187	CcSEcCtD
Nilutamide—Hypertension—Mycophenolic acid—systemic scleroderma	0.000719	0.00187	CcSEcCtD
Nilutamide—Dermatitis—Pentoxifylline—systemic scleroderma	0.000719	0.00186	CcSEcCtD
Nilutamide—Headache—Pentoxifylline—systemic scleroderma	0.000715	0.00185	CcSEcCtD
Nilutamide—Feeling abnormal—Captopril—systemic scleroderma	0.000713	0.00185	CcSEcCtD
Nilutamide—Chest pain—Mycophenolic acid—systemic scleroderma	0.000709	0.00184	CcSEcCtD
Nilutamide—Gastrointestinal pain—Captopril—systemic scleroderma	0.000707	0.00183	CcSEcCtD
Nilutamide—Asthenia—Mometasone—systemic scleroderma	0.000706	0.00183	CcSEcCtD
Nilutamide—Discomfort—Mycophenolic acid—systemic scleroderma	0.000701	0.00182	CcSEcCtD
Nilutamide—Pruritus—Mometasone—systemic scleroderma	0.000697	0.00181	CcSEcCtD
Nilutamide—Ill-defined disorder—Lisinopril—systemic scleroderma	0.000696	0.00181	CcSEcCtD
Nilutamide—Dry mouth—Mycophenolic acid—systemic scleroderma	0.000694	0.0018	CcSEcCtD
Nilutamide—Anaemia—Lisinopril—systemic scleroderma	0.000693	0.0018	CcSEcCtD
Nilutamide—Hyperhidrosis—Leflunomide—systemic scleroderma	0.000689	0.00179	CcSEcCtD
Nilutamide—Body temperature increased—Captopril—systemic scleroderma	0.000684	0.00177	CcSEcCtD
Nilutamide—Abdominal pain—Captopril—systemic scleroderma	0.000684	0.00177	CcSEcCtD
Nilutamide—Oedema—Mycophenolic acid—systemic scleroderma	0.00068	0.00176	CcSEcCtD
Nilutamide—Anorexia—Leflunomide—systemic scleroderma	0.000679	0.00176	CcSEcCtD
Nilutamide—Dry skin—Prednisone—systemic scleroderma	0.000678	0.00176	CcSEcCtD
Nilutamide—Nausea—Pentoxifylline—systemic scleroderma	0.000678	0.00176	CcSEcCtD
Nilutamide—Malaise—Lisinopril—systemic scleroderma	0.000677	0.00175	CcSEcCtD
Nilutamide—Diarrhoea—Mometasone—systemic scleroderma	0.000674	0.00175	CcSEcCtD
Nilutamide—Syncope—Lisinopril—systemic scleroderma	0.000673	0.00174	CcSEcCtD
Nilutamide—Leukopenia—Lisinopril—systemic scleroderma	0.000672	0.00174	CcSEcCtD
Nilutamide—Shock—Mycophenolic acid—systemic scleroderma	0.000669	0.00173	CcSEcCtD
Nilutamide—Alopecia—Mycophenolate mofetil—systemic scleroderma	0.000667	0.00173	CcSEcCtD
Nilutamide—Loss of consciousness—Lisinopril—systemic scleroderma	0.000659	0.00171	CcSEcCtD
Nilutamide—Hyperhidrosis—Mycophenolic acid—systemic scleroderma	0.000657	0.0017	CcSEcCtD
Nilutamide—Cough—Lisinopril—systemic scleroderma	0.000655	0.0017	CcSEcCtD
Nilutamide—Alanine aminotransferase increased—Prednisone—systemic scleroderma	0.000653	0.00169	CcSEcCtD
Nilutamide—Visual disturbance—Methotrexate—systemic scleroderma	0.000653	0.00169	CcSEcCtD
Nilutamide—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.000651	0.00169	CcSEcCtD
Nilutamide—Anorexia—Mycophenolic acid—systemic scleroderma	0.000648	0.00168	CcSEcCtD
Nilutamide—Tension—Mycophenolate mofetil—systemic scleroderma	0.000645	0.00167	CcSEcCtD
Nilutamide—Insomnia—Leflunomide—systemic scleroderma	0.000645	0.00167	CcSEcCtD
Nilutamide—Paraesthesia—Leflunomide—systemic scleroderma	0.00064	0.00166	CcSEcCtD
Nilutamide—Chest pain—Lisinopril—systemic scleroderma	0.000639	0.00166	CcSEcCtD
Nilutamide—Nervousness—Mycophenolate mofetil—systemic scleroderma	0.000638	0.00166	CcSEcCtD
Nilutamide—Back pain—Mycophenolate mofetil—systemic scleroderma	0.000636	0.00165	CcSEcCtD
Nilutamide—Dyspnoea—Leflunomide—systemic scleroderma	0.000635	0.00165	CcSEcCtD
Nilutamide—Discomfort—Lisinopril—systemic scleroderma	0.000631	0.00164	CcSEcCtD
Nilutamide—Dyspepsia—Leflunomide—systemic scleroderma	0.000627	0.00163	CcSEcCtD
Nilutamide—Vomiting—Mometasone—systemic scleroderma	0.000626	0.00162	CcSEcCtD
Nilutamide—Dry mouth—Lisinopril—systemic scleroderma	0.000625	0.00162	CcSEcCtD
Nilutamide—Feeling abnormal—Azathioprine—systemic scleroderma	0.000622	0.00161	CcSEcCtD
Nilutamide—Rash—Mometasone—systemic scleroderma	0.000621	0.00161	CcSEcCtD
Nilutamide—Asthenia—Captopril—systemic scleroderma	0.00062	0.00161	CcSEcCtD
Nilutamide—Dermatitis—Mometasone—systemic scleroderma	0.00062	0.00161	CcSEcCtD
Nilutamide—Decreased appetite—Leflunomide—systemic scleroderma	0.000619	0.00161	CcSEcCtD
Nilutamide—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.000617	0.0016	CcSEcCtD
Nilutamide—Headache—Mometasone—systemic scleroderma	0.000617	0.0016	CcSEcCtD
Nilutamide—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.000615	0.0016	CcSEcCtD
Nilutamide—Insomnia—Mycophenolic acid—systemic scleroderma	0.000615	0.00159	CcSEcCtD
Nilutamide—Oedema—Lisinopril—systemic scleroderma	0.000612	0.00159	CcSEcCtD
Nilutamide—Pruritus—Captopril—systemic scleroderma	0.000612	0.00159	CcSEcCtD
Nilutamide—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.00061	0.00158	CcSEcCtD
Nilutamide—Ill-defined disorder—Mycophenolate mofetil—systemic scleroderma	0.00061	0.00158	CcSEcCtD
Nilutamide—Constipation—Leflunomide—systemic scleroderma	0.000609	0.00158	CcSEcCtD
Nilutamide—Pain—Leflunomide—systemic scleroderma	0.000609	0.00158	CcSEcCtD
Nilutamide—Anaemia—Mycophenolate mofetil—systemic scleroderma	0.000608	0.00158	CcSEcCtD
Nilutamide—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.000606	0.00157	CcSEcCtD
Nilutamide—Shock—Lisinopril—systemic scleroderma	0.000602	0.00156	CcSEcCtD
Nilutamide—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.000598	0.00155	CcSEcCtD
Nilutamide—Body temperature increased—Azathioprine—systemic scleroderma	0.000597	0.00155	CcSEcCtD
Nilutamide—Abdominal pain—Azathioprine—systemic scleroderma	0.000597	0.00155	CcSEcCtD
Nilutamide—Malaise—Mycophenolate mofetil—systemic scleroderma	0.000593	0.00154	CcSEcCtD
Nilutamide—Hyperhidrosis—Lisinopril—systemic scleroderma	0.000592	0.00154	CcSEcCtD
Nilutamide—Diarrhoea—Captopril—systemic scleroderma	0.000592	0.00153	CcSEcCtD
Nilutamide—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000591	0.00153	CcSEcCtD
Nilutamide—Syncope—Mycophenolate mofetil—systemic scleroderma	0.00059	0.00153	CcSEcCtD
Nilutamide—Erectile dysfunction—Prednisone—systemic scleroderma	0.000589	0.00153	CcSEcCtD
Nilutamide—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.000588	0.00153	CcSEcCtD
Nilutamide—Feeling abnormal—Leflunomide—systemic scleroderma	0.000587	0.00152	CcSEcCtD
Nilutamide—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000587	0.00152	CcSEcCtD
Nilutamide—Nausea—Mometasone—systemic scleroderma	0.000585	0.00152	CcSEcCtD
Nilutamide—Anorexia—Lisinopril—systemic scleroderma	0.000584	0.00151	CcSEcCtD
Nilutamide—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000583	0.00151	CcSEcCtD
Nilutamide—Pain—Mycophenolic acid—systemic scleroderma	0.000581	0.00151	CcSEcCtD
Nilutamide—Constipation—Mycophenolic acid—systemic scleroderma	0.000581	0.00151	CcSEcCtD
Nilutamide—Weight decreased—Prednisone—systemic scleroderma	0.000579	0.0015	CcSEcCtD
Nilutamide—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.000578	0.0015	CcSEcCtD
Nilutamide—Hyperglycaemia—Prednisone—systemic scleroderma	0.000577	0.0015	CcSEcCtD
Nilutamide—Cough—Mycophenolate mofetil—systemic scleroderma	0.000574	0.00149	CcSEcCtD
Nilutamide—Dizziness—Captopril—systemic scleroderma	0.000572	0.00148	CcSEcCtD
Nilutamide—Depression—Prednisone—systemic scleroderma	0.000569	0.00147	CcSEcCtD
Nilutamide—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.000568	0.00147	CcSEcCtD
Nilutamide—Abdominal pain—Leflunomide—systemic scleroderma	0.000563	0.00146	CcSEcCtD
Nilutamide—Body temperature increased—Leflunomide—systemic scleroderma	0.000563	0.00146	CcSEcCtD
Nilutamide—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.00056	0.00145	CcSEcCtD
Nilutamide—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.00056	0.00145	CcSEcCtD
Nilutamide—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000556	0.00144	CcSEcCtD
Nilutamide—Insomnia—Lisinopril—systemic scleroderma	0.000554	0.00144	CcSEcCtD
Nilutamide—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000553	0.00143	CcSEcCtD
Nilutamide—Paraesthesia—Lisinopril—systemic scleroderma	0.00055	0.00143	CcSEcCtD
Nilutamide—Vomiting—Captopril—systemic scleroderma	0.00055	0.00143	CcSEcCtD
Nilutamide—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000547	0.00142	CcSEcCtD
Nilutamide—Dyspnoea—Lisinopril—systemic scleroderma	0.000546	0.00142	CcSEcCtD
Nilutamide—Rash—Captopril—systemic scleroderma	0.000545	0.00141	CcSEcCtD
Nilutamide—Dermatitis—Captopril—systemic scleroderma	0.000545	0.00141	CcSEcCtD
Nilutamide—Headache—Captopril—systemic scleroderma	0.000542	0.0014	CcSEcCtD
Nilutamide—Dyspepsia—Lisinopril—systemic scleroderma	0.000539	0.0014	CcSEcCtD
Nilutamide—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000537	0.00139	CcSEcCtD
Nilutamide—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000537	0.00139	CcSEcCtD
Nilutamide—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000537	0.00139	CcSEcCtD
Nilutamide—Decreased appetite—Lisinopril—systemic scleroderma	0.000532	0.00138	CcSEcCtD
Nilutamide—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000529	0.00137	CcSEcCtD
Nilutamide—Shock—Mycophenolate mofetil—systemic scleroderma	0.000528	0.00137	CcSEcCtD
Nilutamide—Constipation—Lisinopril—systemic scleroderma	0.000524	0.00136	CcSEcCtD
Nilutamide—Pain—Lisinopril—systemic scleroderma	0.000524	0.00136	CcSEcCtD
Nilutamide—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000519	0.00135	CcSEcCtD
Nilutamide—Diarrhoea—Azathioprine—systemic scleroderma	0.000516	0.00134	CcSEcCtD
Nilutamide—Nausea—Captopril—systemic scleroderma	0.000514	0.00133	CcSEcCtD
Nilutamide—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000511	0.00133	CcSEcCtD
Nilutamide—Asthenia—Leflunomide—systemic scleroderma	0.000511	0.00133	CcSEcCtD
Nilutamide—Feeling abnormal—Lisinopril—systemic scleroderma	0.000505	0.00131	CcSEcCtD
Nilutamide—Pruritus—Leflunomide—systemic scleroderma	0.000504	0.00131	CcSEcCtD
Nilutamide—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000501	0.0013	CcSEcCtD
Nilutamide—Dizziness—Azathioprine—systemic scleroderma	0.000499	0.00129	CcSEcCtD
Nilutamide—Upper respiratory tract infection—Methotrexate—systemic scleroderma	0.000497	0.00129	CcSEcCtD
Nilutamide—Erectile dysfunction—Methotrexate—systemic scleroderma	0.000492	0.00128	CcSEcCtD
Nilutamide—Asthenia—Mycophenolic acid—systemic scleroderma	0.000488	0.00126	CcSEcCtD
Nilutamide—Diarrhoea—Leflunomide—systemic scleroderma	0.000488	0.00126	CcSEcCtD
Nilutamide—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000485	0.00126	CcSEcCtD
Nilutamide—Abdominal pain—Lisinopril—systemic scleroderma	0.000484	0.00126	CcSEcCtD
Nilutamide—Body temperature increased—Lisinopril—systemic scleroderma	0.000484	0.00126	CcSEcCtD
Nilutamide—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000482	0.00125	CcSEcCtD
Nilutamide—Pruritus—Mycophenolic acid—systemic scleroderma	0.000481	0.00125	CcSEcCtD
Nilutamide—Vomiting—Azathioprine—systemic scleroderma	0.00048	0.00124	CcSEcCtD
Nilutamide—Pneumonia—Methotrexate—systemic scleroderma	0.000479	0.00124	CcSEcCtD
Nilutamide—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000478	0.00124	CcSEcCtD
Nilutamide—Rash—Azathioprine—systemic scleroderma	0.000476	0.00123	CcSEcCtD
Nilutamide—Dermatitis—Azathioprine—systemic scleroderma	0.000475	0.00123	CcSEcCtD
Nilutamide—Depression—Methotrexate—systemic scleroderma	0.000475	0.00123	CcSEcCtD
Nilutamide—Headache—Azathioprine—systemic scleroderma	0.000473	0.00123	CcSEcCtD
Nilutamide—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000472	0.00122	CcSEcCtD
Nilutamide—Dizziness—Leflunomide—systemic scleroderma	0.000471	0.00122	CcSEcCtD
Nilutamide—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000466	0.00121	CcSEcCtD
Nilutamide—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000465	0.00121	CcSEcCtD
Nilutamide—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000463	0.0012	CcSEcCtD
Nilutamide—Pain—Mycophenolate mofetil—systemic scleroderma	0.000459	0.00119	CcSEcCtD
Nilutamide—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000459	0.00119	CcSEcCtD
Nilutamide—Sweating—Methotrexate—systemic scleroderma	0.000457	0.00118	CcSEcCtD
Nilutamide—Haematuria—Methotrexate—systemic scleroderma	0.000454	0.00118	CcSEcCtD
Nilutamide—Vomiting—Leflunomide—systemic scleroderma	0.000453	0.00118	CcSEcCtD
Nilutamide—Alopecia—Prednisone—systemic scleroderma	0.000452	0.00117	CcSEcCtD
Nilutamide—Dizziness—Mycophenolic acid—systemic scleroderma	0.00045	0.00117	CcSEcCtD
Nilutamide—Rash—Leflunomide—systemic scleroderma	0.000449	0.00117	CcSEcCtD
Nilutamide—Dermatitis—Leflunomide—systemic scleroderma	0.000449	0.00116	CcSEcCtD
Nilutamide—Nausea—Azathioprine—systemic scleroderma	0.000448	0.00116	CcSEcCtD
Nilutamide—Headache—Leflunomide—systemic scleroderma	0.000446	0.00116	CcSEcCtD
Nilutamide—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000442	0.00115	CcSEcCtD
Nilutamide—Asthenia—Lisinopril—systemic scleroderma	0.000439	0.00114	CcSEcCtD
Nilutamide—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000439	0.00114	CcSEcCtD
Nilutamide—Pruritus—Lisinopril—systemic scleroderma	0.000433	0.00112	CcSEcCtD
Nilutamide—Vomiting—Mycophenolic acid—systemic scleroderma	0.000432	0.00112	CcSEcCtD
Nilutamide—Rash—Mycophenolic acid—systemic scleroderma	0.000429	0.00111	CcSEcCtD
Nilutamide—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000428	0.00111	CcSEcCtD
Nilutamide—Headache—Mycophenolic acid—systemic scleroderma	0.000426	0.0011	CcSEcCtD
Nilutamide—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000424	0.0011	CcSEcCtD
Nilutamide—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000424	0.0011	CcSEcCtD
Nilutamide—Nausea—Leflunomide—systemic scleroderma	0.000423	0.0011	CcSEcCtD
Nilutamide—Urinary tract disorder—Methotrexate—systemic scleroderma	0.000422	0.0011	CcSEcCtD
Nilutamide—Urethral disorder—Methotrexate—systemic scleroderma	0.000419	0.00109	CcSEcCtD
Nilutamide—Diarrhoea—Lisinopril—systemic scleroderma	0.000419	0.00109	CcSEcCtD
Nilutamide—Ill-defined disorder—Prednisone—systemic scleroderma	0.000413	0.00107	CcSEcCtD
Nilutamide—Visual impairment—Methotrexate—systemic scleroderma	0.000412	0.00107	CcSEcCtD
Nilutamide—Anaemia—Prednisone—systemic scleroderma	0.000412	0.00107	CcSEcCtD
Nilutamide—Dizziness—Lisinopril—systemic scleroderma	0.000405	0.00105	CcSEcCtD
Nilutamide—Nausea—Mycophenolic acid—systemic scleroderma	0.000404	0.00105	CcSEcCtD
Nilutamide—Malaise—Prednisone—systemic scleroderma	0.000402	0.00104	CcSEcCtD
Nilutamide—Syncope—Prednisone—systemic scleroderma	0.0004	0.00104	CcSEcCtD
Nilutamide—Loss of consciousness—Prednisone—systemic scleroderma	0.000392	0.00102	CcSEcCtD
Nilutamide—Vomiting—Lisinopril—systemic scleroderma	0.000389	0.00101	CcSEcCtD
Nilutamide—Rash—Lisinopril—systemic scleroderma	0.000386	0.001	CcSEcCtD
Nilutamide—Dermatitis—Lisinopril—systemic scleroderma	0.000386	0.001	CcSEcCtD
Nilutamide—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000385	0.000998	CcSEcCtD
Nilutamide—Hypertension—Prednisone—systemic scleroderma	0.000385	0.000998	CcSEcCtD
Nilutamide—Headache—Lisinopril—systemic scleroderma	0.000384	0.000995	CcSEcCtD
Nilutamide—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.00038	0.000984	CcSEcCtD
Nilutamide—Alopecia—Methotrexate—systemic scleroderma	0.000378	0.00098	CcSEcCtD
Nilutamide—Discomfort—Prednisone—systemic scleroderma	0.000375	0.000972	CcSEcCtD
Nilutamide—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000367	0.000952	CcSEcCtD
Nilutamide—Nausea—Lisinopril—systemic scleroderma	0.000364	0.000943	CcSEcCtD
Nilutamide—Oedema—Prednisone—systemic scleroderma	0.000364	0.000943	CcSEcCtD
Nilutamide—Back pain—Methotrexate—systemic scleroderma	0.00036	0.000934	CcSEcCtD
Nilutamide—Shock—Prednisone—systemic scleroderma	0.000358	0.000928	CcSEcCtD
Nilutamide—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000355	0.00092	CcSEcCtD
Nilutamide—Hyperhidrosis—Prednisone—systemic scleroderma	0.000352	0.000912	CcSEcCtD
Nilutamide—Anorexia—Prednisone—systemic scleroderma	0.000347	0.000899	CcSEcCtD
Nilutamide—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000346	0.000896	CcSEcCtD
Nilutamide—Anaemia—Methotrexate—systemic scleroderma	0.000344	0.000893	CcSEcCtD
Nilutamide—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000341	0.000885	CcSEcCtD
Nilutamide—Rash—Mycophenolate mofetil—systemic scleroderma	0.000338	0.000877	CcSEcCtD
Nilutamide—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000338	0.000876	CcSEcCtD
Nilutamide—Headache—Mycophenolate mofetil—systemic scleroderma	0.000336	0.000872	CcSEcCtD
Nilutamide—Malaise—Methotrexate—systemic scleroderma	0.000336	0.000871	CcSEcCtD
Nilutamide—Leukopenia—Methotrexate—systemic scleroderma	0.000333	0.000865	CcSEcCtD
Nilutamide—Insomnia—Prednisone—systemic scleroderma	0.000329	0.000853	CcSEcCtD
Nilutamide—Paraesthesia—Prednisone—systemic scleroderma	0.000327	0.000847	CcSEcCtD
Nilutamide—Cough—Methotrexate—systemic scleroderma	0.000325	0.000843	CcSEcCtD
Nilutamide—Dyspepsia—Prednisone—systemic scleroderma	0.00032	0.00083	CcSEcCtD
Nilutamide—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000319	0.000826	CcSEcCtD
Nilutamide—Chest pain—Methotrexate—systemic scleroderma	0.000317	0.000822	CcSEcCtD
Nilutamide—Decreased appetite—Prednisone—systemic scleroderma	0.000316	0.00082	CcSEcCtD
Nilutamide—Discomfort—Methotrexate—systemic scleroderma	0.000313	0.000812	CcSEcCtD
Nilutamide—Constipation—Prednisone—systemic scleroderma	0.000311	0.000807	CcSEcCtD
Nilutamide—Feeling abnormal—Prednisone—systemic scleroderma	0.0003	0.000777	CcSEcCtD
Nilutamide—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000297	0.000771	CcSEcCtD
Nilutamide—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000294	0.000762	CcSEcCtD
Nilutamide—Anorexia—Methotrexate—systemic scleroderma	0.00029	0.000751	CcSEcCtD
Nilutamide—Abdominal pain—Prednisone—systemic scleroderma	0.000287	0.000746	CcSEcCtD
Nilutamide—Body temperature increased—Prednisone—systemic scleroderma	0.000287	0.000746	CcSEcCtD
Nilutamide—Insomnia—Methotrexate—systemic scleroderma	0.000275	0.000713	CcSEcCtD
Nilutamide—Paraesthesia—Methotrexate—systemic scleroderma	0.000273	0.000708	CcSEcCtD
Nilutamide—Dyspnoea—Methotrexate—systemic scleroderma	0.000271	0.000703	CcSEcCtD
Nilutamide—Dyspepsia—Methotrexate—systemic scleroderma	0.000268	0.000694	CcSEcCtD
Nilutamide—Decreased appetite—Methotrexate—systemic scleroderma	0.000264	0.000685	CcSEcCtD
Nilutamide—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000262	0.000681	CcSEcCtD
Nilutamide—Asthenia—Prednisone—systemic scleroderma	0.000261	0.000677	CcSEcCtD
Nilutamide—Pain—Methotrexate—systemic scleroderma	0.00026	0.000674	CcSEcCtD
Nilutamide—Pruritus—Prednisone—systemic scleroderma	0.000257	0.000667	CcSEcCtD
Nilutamide—Feeling abnormal—Methotrexate—systemic scleroderma	0.00025	0.00065	CcSEcCtD
Nilutamide—Diarrhoea—Prednisone—systemic scleroderma	0.000249	0.000645	CcSEcCtD
Nilutamide—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000249	0.000645	CcSEcCtD
Nilutamide—Dizziness—Prednisone—systemic scleroderma	0.00024	0.000624	CcSEcCtD
Nilutamide—Abdominal pain—Methotrexate—systemic scleroderma	0.00024	0.000623	CcSEcCtD
Nilutamide—Body temperature increased—Methotrexate—systemic scleroderma	0.00024	0.000623	CcSEcCtD
Nilutamide—Vomiting—Prednisone—systemic scleroderma	0.000231	0.0006	CcSEcCtD
Nilutamide—Rash—Prednisone—systemic scleroderma	0.000229	0.000595	CcSEcCtD
Nilutamide—Dermatitis—Prednisone—systemic scleroderma	0.000229	0.000594	CcSEcCtD
Nilutamide—Headache—Prednisone—systemic scleroderma	0.000228	0.000591	CcSEcCtD
Nilutamide—Asthenia—Methotrexate—systemic scleroderma	0.000218	0.000566	CcSEcCtD
Nilutamide—Nausea—Prednisone—systemic scleroderma	0.000216	0.00056	CcSEcCtD
Nilutamide—Pruritus—Methotrexate—systemic scleroderma	0.000215	0.000558	CcSEcCtD
Nilutamide—Diarrhoea—Methotrexate—systemic scleroderma	0.000208	0.000539	CcSEcCtD
Nilutamide—Dizziness—Methotrexate—systemic scleroderma	0.000201	0.000521	CcSEcCtD
Nilutamide—Vomiting—Methotrexate—systemic scleroderma	0.000193	0.000501	CcSEcCtD
Nilutamide—Rash—Methotrexate—systemic scleroderma	0.000192	0.000497	CcSEcCtD
Nilutamide—Dermatitis—Methotrexate—systemic scleroderma	0.000191	0.000497	CcSEcCtD
Nilutamide—Headache—Methotrexate—systemic scleroderma	0.00019	0.000494	CcSEcCtD
Nilutamide—Nausea—Methotrexate—systemic scleroderma	0.000181	0.000468	CcSEcCtD
